Literature DB >> 20944996

Socioepidemiological screening of serologically ineligible blood donors due to Chagas disease for the definition of inconclusive cases.

Márcia M Ferreira-Silva1, Gilberto A Pereira, Eliane Lages-Silva, Helio Moraes-Souza.   

Abstract

Epidemiological screening combined with serological tests has become an important tool at blood banks for the characterization of donors with or without Trypanosoma cruzi infection. Thus, the objective of the present study was to describe the sociodemographic and epidemiological characteristics of blood donors with non-negative serology for T. cruzito determine possible risk factors associated with serological ineligibility. Sociodemographic and epidemiological data were collected by analysis of patient histories and interviews. The data were analyzed descriptively using absolute and relative frequencies and odds ratio (OR) evaluation. The frequency of serological ineligibility was 0.28%, with a predominance of inconclusive reactions (52%) and seropositivity among first-time donors (OR = 607), donors older than 30 years (OR = 3.7), females (OR = 1.9), donors from risk areas (OR = 4) and subjects living in rural areas (OR = 1.7). The risk of seropositivity was higher among donors who had contact with the triatomine vector (OR = 11.7) and those with a family history of Chagas disease (OR = 4.8). The results demonstrate the value of detailed clinical-epidemiological screening as an auxiliary tool for serological definition that, together with more specific and more sensitive laboratory methods, will guarantee a higher efficacy in the selection of donors at blood centres.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20944996     DOI: 10.1590/s0074-02762010000600012

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  6 in total

1.  Dealing with initial inconclusive serological results for chronic Chagas disease in clinical practice.

Authors:  J S Lapa; R M Saraiva; A M Hasslocher-Moreno; I Georg; A S Souza; S S Xavier; P E A A do Brasil
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-08       Impact factor: 3.267

2.  Performance of six diagnostic tests to screen for Chagas disease in blood banks andprevalence of Trypanosoma cruzi infection among donors with inconclusive serologyscreening based on the analysis of epidemiological variables.

Authors:  Gilberto de Araujo Pereira; Francisco Louzada-Neto; Valdirene de Fátima Barbosa; Márcia Maria Ferreira-Silva; Helio de Moraes-Souza
Journal:  Rev Bras Hematol Hemoter       Date:  2012

3.  Challenges and perspectives of Chagas disease: a review.

Authors:  Paulo Câmara Marques Pereira; Elaine Cristina Navarro
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2013-12-19

4.  FC-TRIPLEX Chagas/Leish IgG1: a multiplexed flow cytometry method for differential serological diagnosis of chagas disease and leishmaniasis.

Authors:  Andréa Teixeira-Carvalho; Fernanda Magalhães Freire Campos; Stefan Michael Geiger; Roberta Dias Rodrigues Rocha; Fernanda Fortes de Araújo; Danielle Marquete Vitelli-Avelar; Mariléia Chaves Andrade; Márcio Sobreira Silva Araújo; Elenice Moreira Lemos; Anna Bárbara de Freitas Carneiro Proietti; Ester Cerdeira Sabino; Rafaella Gaiotti Caldas; Carolina Renata Camargos Freitas; Ana Carolina Campi-Azevedo; Silvana Maria Elói-Santos; Olindo Assis Martins-Filho
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

Review 5.  Chagasic infection among blood donors in Brazil: an integrative review.

Authors:  Darwin Renne Florencio Cardoso; Léia Madeira Saboia Dos Reis; Ranieri Flávio Viana de Sousa; Elaine Ferreira do Nascimento; Jéssica Pereira Dos Santos; Filipe Aníbal Carvalho-Costa; Jacenir Reis Dos Santos-Mallet
Journal:  Hematol Transfus Cell Ther       Date:  2018-04-18

6.  Cost-Effectiveness of Blood Donation Screening for Trypanosoma cruzi in Mexico.

Authors:  Gilberto Sánchez-González; Alejandro Figueroa-Lara; Miguel Elizondo-Cano; Leslie Wilson; Barbara Novelo-Garza; Leopoldo Valiente-Banuet; Janine M Ramsey
Journal:  PLoS Negl Trop Dis       Date:  2016-03-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.